Results 31 to 40 of about 3,608,607 (227)

Sirolimus for Extracranial Arteriovenous Malformations: A Scoping Review of the Evidence in Syndromic and Non‐Syndromic Cases

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Arteriovenous malformations (AVMs) are rare, high‐flow, vascular anomalies that can occur either sporadically or as part of a genetic syndrome. AVMs can progress with serious morbidity and even mortality if left unchecked. Sirolimus is an mTOR inhibitor that is effective in low‐flow vascular malformations; however, its role in AVMs is unclear.
Will Swansson   +3 more
wiley   +1 more source

abstract [PDF]

open access: yesمجله اقتصاد و توسعه کشاورزی, 2014
abstract abstract
doaj   +4 more sources

Evaluating the Utility of Paired Tumor and Germline Targeted DNA Sequencing for Pediatric Oncology Patients: A Single Institution Report

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Objective To evaluate the diagnostic yield and utility of universal paired tumor–normal multigene panel sequencing in newly diagnosed pediatric solid and central nervous system (CNS) tumor patients and to compare the detection of germline pathogenic/likely pathogenic variants (PV/LPVs) against established clinical referral criteria for cancer ...
Natalie Waligorski   +9 more
wiley   +1 more source

Analiza deformacij s helmertovo transformacijo : Deformation analysis with the helmert transformation [PDF]

open access: yesGeodetski Vestnik, 2012
In the second half of the previous century, analysis of deformations became a highly interesting subject of research and practical application in industry.
Krešimir Frankić ABSTRACT
doaj  

Preferences of Pediatric Patients and Their Caregivers for Chemotherapy‐Induced Nausea and Vomiting Control Endpoints: A Mixed Methods Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Purpose Although not always achieved, complete chemotherapy‐induced nausea and vomiting (CINV) control is the conventional goal of CINV prophylaxis. In this two‐center, mixed‐methods study, we sought to understand the preferences of adolescent patients and family caregivers for CINV control endpoints.
Haley Newman   +8 more
wiley   +1 more source

Intravitreal GD2‐Specific Chimeric Antigen Receptor T‐Cell Therapy for Refractory Retinoblastoma

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Effective treatments for advanced, treatment‐resistant retinoblastoma (RB) remain limited. GD2‐specific chimeric antigen receptor (CAR) T cells show potent antitumor activity with minimal toxicity but have not previously been evaluated in RB.
Subongkoch Subhadhirasakul   +13 more
wiley   +1 more source

Assessing the impact of including sterile 2% chlorhexidine gluconate with 70% isopropyl alcohol applicator in a preoperative skin preparation bundle on surgical siteinfection rate

open access: yesAntimicrobial Stewardship & Healthcare Epidemiology
Objectives: 2% chlorhexidine gluconate (CHG) with 70% isopropyl alcohol (IPA) has been recommended over povidone-iodine (PVI) for skin preparation. BD ChloraPrep™ is a ready-to-use applicator pre-filled with sterile 2% CHG and 70% IPA solution, which ...
Kristin Hui Xian Tan   +2 more
doaj   +1 more source

A dress with a floral design

open access: yesSouth African Family Practice, 1988
No abstract available.
Chris Ellis
doaj   +1 more source

Outcomes of Live Virus Vaccination in Patients With Vascular Anomalies Being Treated With Sirolimus

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Live vaccination in patients with vascular anomalies (VA) receiving sirolimus remains controversial due to immunosuppressive effects and theoretical risks. Procedure This single‐center retrospective study included patients with VA less than 4 years old at the start of sirolimus therapy who were incompletely vaccinated.
Svatava Merkle   +5 more
wiley   +1 more source

Die aard van die persoon wat aan die spits van sake moet staan

open access: yesSouth African Journal of Business Management, 1971
No abstract available.
A. E. Rupert
doaj   +1 more source

Home - About - Disclaimer - Privacy